Clinical Trial Update: Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study [Phase 4]

View source ↗

Summary

This document provides a Phase 4 clinical trial update on rivaroxaban for patients with atrial fibrillation and stable coronary artery disease; the current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stable Coronary Artery Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Japan Cardiovascular Research Foundation | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN